Kubanda Cryotherapy
PrivateLast Round
Convertible Debt
Sep 9, 2025
Total Funding Raised
$2.5M
Company Overview
Kubanda Cryotherapy operates in Healthcare & Life Sciences and is based in Baltimore, Maryland. Its latest recorded funding round was a Convertible Debt round in September 2025.
Kubanda Cryotherapy is a medical device company that develops a minimally invasive cryoablation system for the treatment of benign and malignant tumors in pets.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kubanda Cryotherapy Comparables
Compare Kubanda Cryotherapy with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cortex, Inc. | 66% | |
| HealthTronics | 63% | |
| The Cooper Companies | 61% |
For institutional investors. Book with your work email.
Kubanda Cryotherapy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Sep 9, 2025 | ||||
| Seed | Oct 24, 2024 | ||||
| Pre Seed | Jun 11, 2024 | ||||
| Grant | Aug 7, 2023 | ||||
| Accelerator | Jan 25, 2023 | ||||
Grant | Nov 22, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Kubanda Cryotherapy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boot64 Ventures | Seed |
| The Idea Village | Accelerator |
| TEDCO | Seed, Convertible Debt, Pre Seed |
| Johns Hopkins Technology Ventures | Seed |
| The Stephen and Renee Bisciotti Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 9, 2025
$500K raised in Pre Seed round.
- Jun 11, 2024
$200K round led by TEDCO
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesSep 24, 2026
Kubanda Cryotherapy, Inc introduced CryoDuo, a minimally invasive veterinary treatment for lumps, bumps, and tumors in pets, with dual functionality for topical and subcutaneous applications, in Maryland on Sep 24th '26.
For institutional investors. Book with your work email.
Kubanda Cryotherapy Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kubanda Cryotherapy's valuation, stock price, and market status.
Is Kubanda Cryotherapy a public or private company?
Kubanda Cryotherapy is a private company.
What is the current stock price of Kubanda Cryotherapy?
Kubanda Cryotherapy is a private company, so its shares have no public market price. Caplight tracks Kubanda Cryotherapy's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kubanda Cryotherapy worth (valuation)?
Valuation information for Kubanda Cryotherapy is not publicly available.
Can I buy Kubanda Cryotherapy stock?
Kubanda Cryotherapy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kubanda Cryotherapy's last funding round?
Kubanda Cryotherapy's most recent funding round was Convertible Debt on September 9, 2025.
Who are the main investors in Kubanda Cryotherapy?
Key investors in Kubanda Cryotherapy include TEDCO, The Stephen and Renee Bisciotti Foundation.
Will Kubanda Cryotherapy IPO soon?
No public IPO plans have been announced for Kubanda Cryotherapy.
How can I track Kubanda Cryotherapy secondary market activity?
Caplight tracks bids, offers, and trades in Kubanda Cryotherapy's shares on secondary markets.